4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
11.90
-0.88 (-6.89%)
Oct 30, 2026, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $657.41 million as of October 30, 2026. It is the 12,480th most valuable company in the world and the 2,543rd biggest in the United States. Its market cap has increased by 23.37% in one year.
Market Cap
657.41M
Enterprise Value
265.99M
1-Year Change
23.37%
Global Rank
Country Rank
#2,543 United States
Category
ChartMarket Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $657.41M, an increase of 13.27%. That is a compound annual growth rate of 2.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 657.41M | 53.42% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Attovia Therapeutics | 693.44M |
| SL Science Holding | 684.32M |
| Apnimed | 682.74M |
| Design Therapeutics | 668.37M |
| Solid Biosciences | 664.80M |
| Candel Therapeutics | 637.40M |
| Aura Biosciences | 636.75M |
| Immix Biopharma | 636.69M |